Chronic hepatitis C and G: Status and natural course of GB virus C/hepatitis G virus infection among high-risk groups and volunteer blood donors in Taiwan

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 12, 2000, Pages 1404-1410

  Yu, Ming Lung ^a,b,e   Chuang, Wan Long ^a,b   Wang, Liang Yen ^a,b   Dai, Chia Yen ^a,b   Chiou, Shyh Shin ^a   Sung, Ming Hsing ^a,c   Chang, Chao Sung ^a,b   Chen, Shinn Cherng ^a   Wang, Ching Shan ^d   Chang, Tai Tsung ^a   Chang, Wen Yu ^a,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c Chann Ann Clinic   (Taiwan)

^d Taiwan Blood Services Foundation   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Blood donor; GB virus C; Hemophilia; Hepatitis G virus; Thalassemia; Uremia

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD DONOR; DISEASE COURSE; FEMALE; HEMOPHILIA; HEPATITIS G VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MALE; PRIORITY JOURNAL; SEROCONVERSION; TAIWAN; THALASSEMIA; UREMIA; VIREMIA; VIRUS INFECTION; 5' UNTRANSLATED REGION; FLAVIVIRUS; GENETICS; HEMOPHILIA A; HEPATITIS C; LONGITUDINAL STUDY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PREVALENCE; RISK FACTOR; VIROLOGY; VIRUS HEPATITIS;

5' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BLOOD DONORS; FEMALE; FLAVIVIRIDAE; HEMOPHILIA A; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; THALASSEMIA; UREMIA; VIREMIA;

EID: 0034565092     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02359.x     Document Type: Article

References (31)

1. Isolation of novel virus-like sequences associated with human hepatitis
2. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent
3. Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human non-A-E hepatitis
4. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown etiology
5. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection
6. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease
7. Association between fulminant hepatic failure and a strain of GBV virus C
8. A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma
9. Detection of antibodies to a putative hepatitis G virus envelope protein
10. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors
11. Three different GB virus C/hepatitis G virus genotypes Phylogenetic analysis and a genotyping assay based on restriction fragment length polymorphism
12. GB virus C/hepatitis G virus infection among Japanese patients with chronic liver diseases and blood donors
13. Sequence heterogeneity within the 5′-terminal region of the hepatitis GB virus C genome and evidence for genotypes
14. Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5′ non-coding region
15. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients
16. Distinct prevalence of antibodies to the E2 protein of GB virus C/hepatitis G virus in different parts of the world
17. Sequence variation and phylogenetic analysis of envelope glycoprotein of hepatitis G virus
18. Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: Evidence of sexual and parenteral transmission
19. High prevalence of GB virus C in Brazil and molecular evidence for intrafamilial transmission
20. The incidence and natural course of transfusion-associated GB virus C/hepatitis G virus infection in a cohort of thalassemic patients
21. Infection with hepatitis G virus among recipients of plasma products
22. HGV in coagulation-factor concentrates
23. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization
24. Limited humoral immunity in hepatitis C virus infection
25. Hepatitis C infection unrelated to blood transfusion in hemodialysis patients
26. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study
27. Genetic diversity between hepatitis G virus isolates: Analysis of nucleotide variation in the NS-3 and putative 'core' peptide genes
28. Identification of GB virus C variants by phylogenetic analysis of 5′-untranslated and coding region sequences
29. Phylogenetic analysis of GB virus C. Comparison of isolates from Africa, North America, and Taiwan
30. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: High prevalence of HGV infection and spontaneous remission
31. Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan